Skip to main content
. 2014 Jul 9;14:500. doi: 10.1186/1471-2407-14-500

Table 5.

Criteria used to build a prognostic score for patient selection for RFA treatment of liver-only CLM in the context of effective modern-agent systemic therapies

Variable Reference category Points
Systemic therapy
Objective response1
1
Number of CLM
≤ 3 CLM
1
Maximum size of CLM
≤ 3 cm2
1
CEA level ≤ 100 ng/mL 1

Abbreviations: CEA, carcinoembryonic antigen; CLM, colorectal liver metastases; RFA, radiofrequency ablation.

1RECIST-defined response to the immediate preceding systemic therapy regimen before RFA treatment. 2after decrease of ≥30% in size following the immediate preceding systemic therapy regimen before RFA treatment.